Reports

357 Results (Page 9 of 15)

South Africa Markets Research Reports

Pharmaceuticals

South Africa Gynecology Drugs Market Analysis

South Africa Gynecology Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gynecology drugs market include the increasing prevalence of gynecological disorders, growing awareness and focus on women's health, technological advancements, and supportive government initiatives promoting women's healthcare. Key Global Players in Gynecology Drugs Market are Bayer AG, Pfizer Inc., Merck & Co., Novartis AG, Johnson & Johnson, AbbVie Inc., Allergan plc, Eli Lilly and Company, AstraZeneca plc and GlaxoSmithKline plc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa H1N1 Vaccines Market Analysis

South Africa H1N1 Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the H1N1 vaccines market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Haematology Market Analysis

South Africa Haematology Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing frequency of blood disorders, technological improvements, the growing elderly population, and increased desire for customised medicine and focused therapies are key drivers of the haematology market. Abbott Laboratories, Sysmex Corporation, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), HORIBA Ltd., Ortho Clinical Diagnostics, and Agilent Technologies are the global players in the haematology market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Hangover Rehydration Supplements Market Analysis

South Africa Hangover Rehydration Supplements Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing ageing population and prevalence of chronic diseases, breakthroughs in medication discovery and technology, and increased access to healthcare in emerging economies are all key drivers of the Hangover Rehydration Supplements Market. Gatorade (PepsiCo), Pedialyte (Abbott Laboratories), Liquid IV, Flyby, Blowfish for Hangovers, Cheers Health Inc., Bytox, Morning Recovery, Resync Recovery Blend, and Hydrant are the global key players in the Hangover Rehydration Supplements Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Head and Neck Cancer Drugs Market Analysis

South Africa Head and Neck Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the head and neck cancer drugs market in the USA include the increasing incidence of head and neck cancer, advancements in treatment options, rising demand for personalized medicine, and supportive government initiatives. Global Companies in Head and Neck Cancer Drugs Market are Bristol Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Roche Holding AG, Takeda Pharmaceutical Company Limited, Bayer AG, AbbVie Inc. and Eisai Co., Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Heart Failure Drugs Market Analysis

South Africa Heart Failure Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drivers of the heart failure drugs market include the increasing prevalence of heart failure, the aging population, advancements in drug therapies, rising awareness and diagnosis, and supportive government initiatives. Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, Merck & Co., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Bayer AG, GlaxoSmithKline plc and Amgen are global key players in Heart Failure Drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Hematopoietic Stem Cell Transplantation Market Analysis

South Africa Hematopoietic Stem Cell Transplantation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Two significant drivers driving the global market expansion for hematopoietic stem cell transplantation are leukaemia and lymphoproliferative disorders. Rising technical advancements and significant companies spending more money on R&D are expected to drive the market. Some of the major key players are Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Heparin Market Analysis

South Africa Heparin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Deep vein thrombosis (DVT) and pulmonary embolism (PE), expanding cardiac disorders, rising federal funding for improving health services and comprehensive research and development (R&D) activities, the rising incidence of chronic diseases, and the ageing population are some of the market drivers influencing the growth of the heparin market. The global Heparin market’s major key players are Sanofi S.A., Viatris Inc., Pfizer Inc., B. Braun Holding GmbH & Co. KG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Hepatitis B Drugs Market Analysis

South Africa Hepatitis B Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors such as growth of pharmaceutical industry, increase in ageing population, upsurge in healthcare expenditure, urbanization leading to better monitoring and screening procedures and increase in liver cancer and cirrhosis deaths due to HBV would drive the growth of Hepatitis B drugs market. Some of the major key players in this market are Apotex Inc, Accord Healthcare, Arbutus Biopharma, Aurobindo Pharma, Arrowhead Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences, Inc., Lupin Pharmaceuticals, Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Hepatitis C Drugs Market Analysis

South Africa Hepatitis C drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market will grow as a result of a number of factors, including the expansion of the pharmaceutical sector, an ageing population, growing healthcare expenditures, urbanisation, better monitoring and screening technologies, and a rise in liver cancer and cirrhosis fatalities brought on by HBV. Some of the major key players in this market are Bristol-Myers Squibb Company Gilead Sciences, Inc. Abbvie Kadmon Holdings Inc. F. Hoffmon La Roche Ltd. GlaxoSmithKline J & J Lupin Pharmaceuticals, Inc. Merck & Co., Inc. Teva Pharmaceuticals and Zydus Pharmaceuticals.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa HER-2 Negative Breast Cancer Market Analysis

South Africa HER-2 Negative Breast Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. A number of factors, such as age, obesity, alcoholism, radiation exposure history, family history of breast cancer, family history of the disease, age at first pregnancy, onset of the menstrual cycle, and tobacco use, increase the risk of developing the disease. As a result of lifestyle changes, the incidence and prevalence of breast cancer are rising quickly. All of this will drive a HER-2 Negative Breast Cancer Market.The global HER-2 Negative Breast Cancer market’s major key players are Pfizer, Novartis AG Merck & Co. Inc., GlasxoSmithKline, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca, Lupin, Bayer AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Herceptin Biosimilar Market Analysis

South Africa herceptin biosimilar market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market grows as a result of increased research and development as well as rising public knowledge of cancer treatments. Additionally, rising healthcare costs and the existence of innovative pipeline products create an opportunity for market expansion. Some of the key players in this market are Mylan N.V., Amgen Inc., Mabion S.A., AryoGen Biopharma, Genor Biopharma, Celltrion Inc., Gedeon Richter Plc, The Instituto Vital Brazil, F. Hoffmann-La Roche AG, and Biocon.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Homeopathy Product Market Analysis

South Africa homeopathy product market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030.The market will increase significantly during the forecast period as a result of the ageing and growing paediatric populations. During the forecast period, rising use of homoeopathy as a holistic treatment is anticipated to drive market expansion. Some of the key players in this market are Boiron, Biologische Heilmittel Heel GmbH, A Nelson & Co Ltd, Homeocan, SBL, Hahnemann Laboratories, Medisynth, Ainsworths Ltd., Hevert - Arzneimittel GmbH & Co. KG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Human Insulin Drugs Market Analysis

South Africa Human Insulin Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. An increasing number of people with diabetes, increased exposure to key diabetes risk factors, rising market demand for human insulin analogues, technological advancements in the field of human insulin delivery devices, and favourable medical reimbursements are all expected to lead to an increase in the global market for human insulin. Some of the key players in this market are Sanofi (France), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (UAE), Ypsomed AG (Switzerland), BD (U.S.), etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Human Papillomavirus (HPV) Vaccine Market Analysis

South Africa Human Papillomavirus (HPV) vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for HPV vaccines is mainly being driven by the rising need for prevention of these infections as well as the rising prevalence of human papillomavirus (HPV)-related malignancies of the anus, vulva, vagina, penis, and oropharynx. Some of the key players in this market are Xenetic Biosciences, Inc., Bharat Biotech., AstraZeneca, GlaxoSmithKline plc., Johnson & Johnson, Serum Institute of India Pvt. Ltd, Inovio Pharmaceuticals, Inc, Novartis AG, Sanofi, Merck & Co., Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Human Rotavirus Vaccine Market Analysis

South Africa human rotavirus vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing global supply of goods to comply with and meet the demands of immunisation strategies to eradicate endemic diseases is one of the major reasons boosting market expansion. Globally, there is more government control to ensure that everyone has access to low- or no-cost immunizations. All these factors will drive the growth of human rotavirus vaccine market. Some of the key players in this market are GlaxoSmithKline plc. (UK), Sanofi (France), Pfizer Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Emergent BioSolutions, Inc. (US), CSL Limited (Australia), Inovio Pharmaceuticals, Inc. (US), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan).

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Immune Checkpoint Inhibitors Market Analysis

South Africa immune checkpoint inhibitors market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for immune checkpoint inhibitors is expanding as a result of factors such as leading an unhealthy lifestyle, a rise in cancer incidence, and genetic mutation and alteration that have an impact on how much the nation's healthcare systems cost. Some of the global key players in this market are AstraZeneca PLC, Eli Lilly and Company (ARMO Biosciences.), Bristol-Myers Squibb Company, Roche Holding AG, Incyte Corporation, Novartis AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Immunosuppressant Drugs Market Analysis

South Africa immunosuppressant drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factor fueling the growth of the immunosuppressants market is the rise in autoimmune illnesses like multiple sclerosis, alopecia areata, and arthritis. The market growth for immunosuppressants is also influenced by an increase in organ transplant procedures, such as kidney and liver transplants, which is brought on by an increase in the incidence of organ failure. Some of the major key players are Intas Pharmaceuticals Ltd. (Accord Healthcare Ltd.), Mylan N.V., AbbVie Inc., Sanofi S.A., GlaxoSmithKline Plc., Astellas Pharma Inc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer Inc., Novartis International AG (Sandoz), Bristol-Myers Squibb Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Infection Control Supplies Market Analysis

South Africa infection control supplies market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The key drivers driving the infection control sector are the expanding number of procedures that call for control measures to stop spreading and the increased prevalence of nosocomial infections. The key players in this market are 3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics International, MMM Group, Cantel Medical Corporation, STERIS Corporation.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Infectious Wound Care Management Market Analysis

South Africa infectious wound care management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expanding as a result of the ageing population, the prevalence of chronic diseases, and technologically advanced and lifestyle-related wound care products. The key players in this market are Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp, Medtronic, 3M, Derma Sciences Inc. (Integra LifeSciences), Medline Industries, Advancis Medical, B. Braun Melsungen AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Inflammatory Bowel Disease (IBD) Drugs Market Analysis

South Africa Inflammatory Bowel Disease (IBD) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Numerous variables, including genetic predisposition, environmental triggers, and immune system disturbance, are to blame for the rising prevalence of ulcerative colitis and Crohn's disease. Most people who have ulcerative colitis or Crohn's disease have a family history of the condition. This will act as a driver for Inflammatory Bowel Disease (IBD) drugs market. AbbVie Inc. (U.S.) Takeda Pharmaceutical Company Limited (Tokyo) UCB S.A. (Belgium) Bausch Health Companies Inc. (Canada) Bristol-Myers Squibb Company (U.S.) Pfizer Inc. (U.S.) Celltrion Inc. (South Korea) Johnson & Johnson Services, Inc. (U.S.) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Influenza Medications Market Analysis

South Africa influenza medications market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to factors such an increase in influenza cases and increasing research and development for drug development initiatives, the global market for anti-flu medications is anticipated to rise. As a result of technological developments that generate a significant pipeline of novel pharmaceuticals, this industry may experience growth. Sanofi S.A, Lupin Limited, Teva Pharmaceutical Industries Ltd, Shionogi & Co. Ltd, Macleods Pharmaceutical Ltd, Alvogen Pvt. Ltd, AstraZaneca Plc, BioCryst Pharmaceuticals Inc, F. Hoffman La Roche Ltd, Novartis AG, Vitaris AG. Are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Influenza Vaccine Market Analysis

South Africa influenza vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The government's increased emphasis on and support for the influenza vaccination is one of the major factors influencing the global market. Leading market players like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures in order to enhance their production capabilities and concentrate on the introduction of new vaccines, which is what is causing the industry to continue to grow. GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), Sinovac (China) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Inhalation Anesthesia Market Analysis

South Africa inhalation anesthesia market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expected to grow as a result of rising healthcare R&D spending and recent technological and scientific advancements. The market is anticipated to expand because to the rising demand for shorter hospital stays and more accessibility to healthcare services. Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, AbbVie Inc are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Inhaled Nitric Oxide Market Analysis

South Africa inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up